-
Is Quest Diagnostics a Great Dividend Stock?
Post on 8/31/20
-
Assembly Biosciences and Arbutus Biopharma Announce Clinical Collaboration Agreement
Post on 8/30/20
-
Pfizer Is Out, Honeywell Is In: Should The Dow Jones Shake-Up Change Your Investing Strategy?
Post on 8/28/20
-
Parker Health Group Teams Up with AARP Foundation
Post on 8/27/20
-
3 Green Flags for Pfizer's Future
Post on 8/27/20
-
Pfizer Says It Has Over 50% Enrollment for Coronavirus Vaccine Candidate Trial
Post on 8/27/20
-
Children's Hospital of Philadelphia Opens Nicholas and Athena Karabots Primary Care Center in Norristown
Post on 8/26/20
-
Delta Dental Community Care Foundation Awards Nearly $950,000 in Grants to Pennsylvania Nonprofits
Post on 8/26/20
-
MetLife Investment Management Originates $6.2 Billion in Private Placement Debt For 1H 2020
Post on 8/26/20
-
Inovio: A Viable Short, Falling Behind The Leaders In COVID-19 Vaccine Development
Post on 8/26/20
-
Inovio: Falling Behind The Leaders In COVID-19 Vaccine Development, A Very Viable Short
Post on 8/25/20
-
Otsuka America Pharmaceutical Purchases the Assets of Proteus Digital Health
Post on 8/25/20
-
Penn State Cancer Institute Joins Caris Life Sciences' Precision Oncology Alliance
Post on 8/25/20
-
Pfizer's Stock May Be Heading For A Big Breakout
Post on 8/25/20
-
Catalent Signs Agreement with AstraZeneca
Post on 8/24/20
-
Yumanity Therapeutics and Proteostasis Therapeutics Merge
Post on 8/24/20
-
Pfizer and BioNTech's Coronavirus Vaccine Candidate Produces Antibodies in People Up to 85 Years Old
Post on 8/24/20
-
Harmony Biosciences Closes Its Upsized IPO
Post on 8/23/20
-
Enzon Pharmaceuticals Anticipated Rights Offering to Existing Shareholders
Post on 8/23/20
-
Why Is Everyone Talking About Pfizer?
Post on 8/21/20
-
Johnson & Johnson to Launch Late-Stage Coronavirus Vaccine Trials in September
Post on 8/21/20
-
3 Life Science and Health IT Companies Raise Funds — and One Goes Public
Post on 8/20/20
-
Harmony Biosciences Announces Pricing Of Upsized Initial Public Offering
Post on 8/19/20
-
Johnson & Johnson to Acquire Momenta Pharmaceuticals for $6.5B
Post on 8/19/20
-
J&J To Acquire Momenta Pharmaceuticals For $6.5B
Post on 8/19/20
Philadelphia
